Aybintio 400 mg (Bevacizumab SOLUTION) 400 MG

AYBINTIO 400 MG is a bevacizumab solution for intravenous use, designed for targeted therapy. This medication is used to treat certain types of cancer and may help slow tumor growth.

Strength

400 MG

Manufacturer / TM Owner

SAMSUNG BIOEPIS CO., LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AYBINTIO 400 MG is a bevacizumab solution primarily used in the treatment of specific cancers. It works by targeting and inhibiting the growth of new blood vessels that supply tumors, which can help slow the progression of cancer. This medication is often used in combination with other cancer treatments to enhance their effectiveness. Patients should consult their healthcare provider to determine if AYBINTIO 400 MG is suitable for their condition.

Side Effects

Common effects of AYBINTIO 400 MG may include fatigue, high blood pressure, and changes in appetite. Some patients may experience more severe side effects, such as bleeding or wound healing problems. It is important to monitor for any unusual symptoms and report them to a healthcare professional.

Precautions & Warnings

AYBINTIO 400 MG should be handled with care and administered by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients with a history of bleeding disorders or those taking blood-thinning medications should use this medication with caution. Always inform your healthcare provider about any pre-existing conditions or medications you are taking.

Avoid Interactions

AYBINTIO 400 MG may interact with other medications, particularly those that affect blood clotting or the immune system. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be avoided as it may exacerbate certain side effects.

Frequently Asked Questions

AYBINTIO 400 MG is used in the treatment of certain types of cancer by inhibiting the growth of new blood vessels that supply tumors.

AYBINTIO 400 MG is administered intravenously by a healthcare professional.

Common side effects may include fatigue, high blood pressure, and changes in appetite.

AYBINTIO 400 MG may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Patients with a history of bleeding disorders or those taking blood-thinning medications should use AYBINTIO 400 MG with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.